Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Pranoprofen

Drug Profile

Pranoprofen

Alternative Names: Difen Oculum; difen oculum; Niflan; Niflan Ophthalmic Solution; Oftalar; Pranopulin Ophthalmic Solution; Pranox; SJH 1012; Y 8004

Latest Information Update: 05 Aug 2015

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Mitsubishi Pharma Corporation
  • Developer Alcon Cusi; Allergan; Mitsubishi Tanabe Pharma Corporation; Senju Pharmaceutical; Takeda
  • Class Benzopyrans; Nonsteroidal anti-inflammatories; Propionic acids
  • Mechanism of Action Cyclooxygenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Fever; Inflammation; Ocular inflammation; Pain

Most Recent Events

  • 01 Oct 2007 Mitsubishi Pharma Corporation has merged with Tanabe Seiyaku to form Mitsubishi Tanabe Pharma Corporation
  • 06 Apr 2000 Yoshitomi is now called Welfide Corporation
  • 31 Dec 1999 Launched for Ocular inflammation in Czech Republic (Ophthalmic)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top